Archived Newsletters

31. 07.08.19 -- The Challenges Of Biopharmaceutical Quality
    7/8/2019
    07/08/19 Outsourced Pharma Newsletter
32. 07.03.19 -- FDA Leads, C-Suite Lags Continuous Manufacturing Acceptance
    7/3/2019
    07/03/19 Outsourced Pharma Newsletter
33. 06.28.19 -- Seven Strategies To Avoid Delays In Clinical Supply
    6/28/2019
    06/28/19 Outsourced Pharma Newsletter
34. 06.27.19 -- The Future Of Biopharmaceuticals In Emerging Asia Pacific Markets
    6/27/2019
    06/27/19 Outsourced Pharma Newsletter
35. 06.26.19 -- New FDA Quality Report -- A World Full Of Inspections
    6/26/2019
    06/26/19 Outsourced Pharma Newsletter
36. 06.25.19 -- Strategies In Drug Development And Manufacturing
    6/25/2019
    06/25/19 Outsourced Pharma Newsletter
37. 06.24.19 -- Comparing Continuous And Batch Processing In Downstream Purification
    6/24/2019
    06/24/19 Outsourced Pharma Newsletter
38. 06.19.19 -- Ranbaxy Revisited: Why We Need To Look Back
    6/19/2019
    06/19/19 Outsourced Pharma Newsletter
39. 06.18.19 -- Process Development And Regulatory Guidance For Today's Biomanufacturing Challenges
    6/18/2019
    06/18/19 Outsourced Pharma Newsletter
40. 06.12.19 -- 10 Questions For "Make Vs. Buy" In Drug Development And Manufacturing
    6/12/2019
    06/12/19 Outsourced Pharma Newsletter